Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 4, 2007, Pages 1037-1042

  Nishimori, Isao ^a   Innocenti, Alessio ^b   Vullo, Daniela ^b   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anion; Anion exchanger; Carbonic anhydrase; Cyanide; Enzyme inhibitor; Secreted isoform

Indexed keywords

ANION; AZIDE; BICARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CHLORIDE; CYANIDE; NITRATE; SULFANILAMIDE;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; ENZYME PURIFICATION; HUMAN; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ACETAZOLAMIDE; AMINO ACID SEQUENCE; ANIONS; BUFFERS; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASE IV; CATALYSIS; CLONING, MOLECULAR; CYTOSOL; HUMANS; KINETICS; METALLOPROTEINS; MOLECULAR SEQUENCE DATA;

EID: 33846463703     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.11.028     Document Type: Article

References (49)

1. Supuran, C. T.; Scozzafava, A.; Conway, J., Eds.; Carbonic Anhydrase-Its Inhibitors and Activators. CRC Press: Boca Raton, New York, London, 2004; p 1-363.
2. Pastorekova S., Parkkila S., Pastorek J., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 19 (2004) 199
3. Scozzafava A., Mastrolorenzo A., and Supuran C.T. Expert Opin. Ther. Pat. 14 (2004) 667
4. Supuran C.T. Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton 1-23
5. Supuran C.T., Scozzafava A., and Casini A. Med. Res. Rev. 23 (2003) 146
6. Supuran C.T., Scozzafava A., and Casini A. Development of Sulfonamide Carbonic Anhydrase Inhibitors. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton 67-147
7. Winum J.Y., Montero J.L., Scozzafava A., and Supuran C.T. Mini-Rev. Med. Chem. 6 (2006) 921
8. Smith K.S., Jakubzick C., Whittam T.S., and Ferry J.G. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 15184
9. Sly W.S., and Hu P.Y. Annu. Rev. Biochem. 64 (1995) 375
10. Lehtonen J., Shen B., Vihinen M., Casini A., Scozzafava A., Supuran C.T., Parkkila A.K., Saarnio J., Kivela A.J., Waheed A., Sly W.S., and Parkkila S. J. Biol. Chem. 279 (2004) 2719
11. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., Wilson G.D., Turley H., Talks K.L., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Harris A.L. Cancer Res. 60 (2000) 7075
12. Potter C.P.S., and Harris A.L. Brit. J. Cancer 89 (2003) 2
13. Supuran C.T., and Scozzafava A. Activation of Carbonic Anhydrase Isozymes. In: Chegwidden W.R., Carter N., and Edwards Y. (Eds). The Carbonic Anhydrases-New Horizons (2000), Birkhauser, Verlag, Basel, Switzerland 197-219
14. Ilies M., Scozzafava A., and Supuran C.T. Carbonic Anhydrase Activators. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton (FL), USA 317-352
15. Bahn Y.S., and Muhlschlegel F.A. Curr. Opin. Microbiol. 9 (2006) 1
16. Hilvo M., Tolvanen M., Clark A., Shen B., Shah G.N., Waheed A., Halmi P., Hanninen M., Hamalainen J.M., Vihinen M., Sly W.S., and Parkkila S. Biochem. J. 392 (2005) 83
17. Nishimori I. Acatalytic CAs: Carbonic Anhydrase-Related Proteins. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton (FL), USA 25-43
18. Fernley R.T., Wright R.D., and Coghlan J.P. FEBS Lett. 105 (1979) 299
19. Aldred P., Fu P., Barrett G., Penschow J.D., Wright R.D., Coghlan J.P., and Fernley R.T. Biochemistry 30 (1981) 569
20. Fernley R.T. Secreted Carbonic Anhydrases. In: Botrè F., Gros G., and Storey B.T. (Eds). Carbonic Anhydrase-From Biochemistry and Genetics to Physiology and Clinical Medicine (1991), VCH, Weinheim 178-185
21. Kivela J., Parkkila S., Parkkila A.K., Leinonen J., and Rajaniemi H. J. Physiol. 520 (1999) 315
22. Murakami H., and Sly W.S. J. Biol. Chem. 262 (1987) 1382
23. Karhumaa P., Leinonen J., Parkkila S., Kaunisto K., Tapanainen J., and Rajaniemi H. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11604
24. Ogawa Y., Matsumoto K., Maeda T., Tamai R., Suzuki T., Sasano H., and Fernley R.T. J. Histochem. Cytochem. 50 (2002) 821
25. Smith, C. E.; Nanci, A.; Moffatt P. Eur. J. Oral Sci. 2006, 114, Suppl 1, 147.
26. Nishimori I., Vullo D., Innocenti A., Scozzafava A., Mastrolorenzo A., and Supuran C.T. J. Med. Chem. 48 (2005) 7860
27. 19
28. Khalifah R.G., Strader D.J., Bryant S.H., and Gibson S.M. Biochemistry 16 (1977) 2241
29. 2 concentrations ranged from 1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants. For each inhibitor at least six traces of the initial 5-10% of the reaction have been used for determining the initial velocity. The uncatalyzed rates were determined in the same manner and subtracted from the total observed rates. Stock solutions of inhibitor (10 mM) were prepared in distilled-deionized water and dilutions up to 0.01 μM were done thereafter with distilled-deionized water. Inhibitor and enzyme solutions were preincubated together for 15 min at room temperature prior to assay, in order to allow for the formation of the E-I complex. The inhibition constants were obtained by non-linear least-squares methods using PRISM 3, from Lineweaver-Burk plots, as reported earlier, and represent the mean from at least three different determinations.
30. Casini A., Antel J., Abbate F., Scozzafava A., David S., Waldeck H., Schafer S., and Supuran C.T. Bioorg. Med. Chem. Lett. 13 (2003) 841
31. Abbate F., Coetzee A., Casini A., Ciattini S., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 14 (2004) 337
32. Temperini C., Vullo D., Scozzafava A., and Supuran C.T. J. Med. Chem. 49 (2006) 3019
33. Tashian R.E., Venta P.J., Nicewander P.H., and Hewett-Emmett D. Prog. Clin. Biol. Res. 344 (1990) 159
34. Vullo D., Franchi M., Gallori E., Antel J., Scozzafava A., and Supuran C.T. J. Med. Chem. 47 (2004) 1272
35. Vullo D., Innocenti A., Nishimori I., Pastorek J., Scozzafava A., Pastorekova S., and Supuran C.T. Bioorg. Med. Chem. Lett. 15 (2005) 963
36. Nair S.K., and Christianson D.W. J. Am. Chem. Soc. 113 (1991) 9455
37. Christianson D.W., and Fierke C.A. Acc. Chem. Res. 29 (1996) 331
38. Whittington D.A., Grubb J.H., Waheed A., Shah G.N., Sly W.S., and Christianson D.W. J. Biol. Chem. 279 (2004) 7223
39. Vullo D., Franchi M., Gallori E., Pastorek J., Scozzafava A., Pastorekova S., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 18 (2003) 403
40. Winum J.Y., Innocenti A., Nasr J., Montero J.L., Scozzafava A., Vullo D., and Supuran C.T. Bioorg. Med. Chem. Lett. 15 (2005) 2535
41. Innocenti A., Firnges M., Antel J., Wurl M., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 14 (2004) 5769
42. Lehtonen J., Parkkila S., Vullo D., Casini A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 14 (2004) 3757
43. Innocenti A., Vullo D., Scozzafava A., Casey J.R., and Supuran C.T. Bioorg. Med. Chem. Lett. 15 (2005) 573
44. Franchi M., Vullo D., Gallori E., Antel J., Wurl M., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 13 (2003) 2857
45. Innocenti A., Vullo D., Scozzafava A., and Supuran C.T. Biorg. Med. Chem. Lett. 15 (2005) 567
46. Innocenti A., Antel J., Wurl M., Vullo D., Firnges M.A., Scozzafava A., and Supuran C.T. Biorg. Med. Chem. Lett. 15 (2005) 1909
47. Vullo D., Ruusuvuori E., Kaila K., Scozzafava A., and Supuran C.T. Biorg. Med. Chem. Lett. 16 (2006) 3139
48. Sterling D., Reithmeier R.A., and Casey J.R. J. Biol. Chem. 276 (2001) 47886
49. McMurtrie H.L., Alvarez B.V., Loiselle F.B., Sterling D., Morgan P.E., Cleary H.J., Johnson D.E., and Casey J.R. J. Enzyme Inhib. Med. Chem. 19 (2004) 231